Current Strengths and Weaknesses of ChatGPT as a Resource for Radiation Oncology Patients and Providers.

Journal: International journal of radiation oncology, biology, physics
Published Date:

Abstract

PURPOSE: Chat Generative Pre-Trained Transformer (ChatGPT), an artificial intelligence program that uses natural language processing to generate conversational-style responses to questions or inputs, is increasingly being used by both patients and health care professionals. This study aims to evaluate the accuracy and comprehensiveness of ChatGPT in radiation oncology-related domains, including answering common patient questions, summarizing landmark clinical research studies, and providing literature reviews with specific references supporting current standard-of-care clinical practice in radiation oncology.

Authors

  • Warren Floyd
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Troy Kleber
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • David J Carpenter
    Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina; Radiation Oncology Clinical Service, Durham VA Health Care System, Durham, North Carolina.
  • Melisa Pasli
    Brody School of Medicine, East Carolina University, Greenville, North Carolina.
  • Jamiluddin Qazi
    Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina; Radiation Oncology Clinical Service, Durham VA Health Care System, Durham, North Carolina.
  • Christina Huang
    Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina; Radiation Oncology Clinical Service, Durham VA Health Care System, Durham, North Carolina.
  • Jim Leng
    Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina; Radiation Oncology Clinical Service, Durham VA Health Care System, Durham, North Carolina.
  • Bradley G Ackerson
    Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina; Radiation Oncology Clinical Service, Durham VA Health Care System, Durham, North Carolina.
  • Matthew Pierpoint
    Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina.
  • Joseph K Salama
    Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina; Radiation Oncology Clinical Service, Durham VA Health Care System, Durham, North Carolina.
  • Matthew J Boyer
    Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina; Radiation Oncology Clinical Service, Durham VA Health Care System, Durham, North Carolina. Electronic address: Matthew.Boyer@duke.edu.